Healthcare Triangle Registers 28M Shares for $50M Equity Line — Pricing at 6% Discount to Market

summarizeSummary

Healthcare Triangle registered 28 million shares for a $50 million equity line with pricing at a 6% discount to market, threatening massive dilution for existing holders.

check_boxKey Events · Financing and Capital Events · HCTI

• 28M Shares Registered for $50M Equity Line

  The prospectus registers 28 million shares for resale by Hudson Global Ventures under an equity line of credit established June 12, 2026, with up to $50 million in potential proceeds.

• Pricing at 6% Discount to Market

  Purchase price is the lesser of 94% of the average of the three lowest traded prices over five days or 94% of the lowest price during the valuation period — a built-in discount that deepens dilution.

• Massive Dilution Potential

  At the current $1.89 stock price, full utilization would require issuing approximately 26.5 million shares, nearly doubling the 2.03 million shares outstanding and diluting existing holders by over 90%.

• Warrant Issued as Commitment Fee

  A warrant to purchase 50,000 shares at $0.00001 per share was issued to the selling stockholder, adding to the dilutive impact.

auto_awesomeAnalysis · HCTI · Technology

A prospectus supplement filed by Healthcare Triangle registers 28 million shares for resale by Hudson Global Ventures under a $50 million equity line of credit established in June. The purchase price is set at a 6% discount to the market — the lesser of 94% of the three lowest traded prices over five days or 94% of the lowest price during the valuation period. At the current $1.89 stock price, full utilization would require issuing roughly 26.5 million shares, nearly doubling the outstanding share count and causing severe dilution. While the company retains discretion over drawdowns, the deeply discounted pricing and massive overhang create significant downward pressure on the stock. This filing follows a series of highly dilutive financing moves, including a $3.6 million convertible note and a $50 million equity line, as the company burns cash and seeks shareholder approval for even more dilution.